Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs

Gene

Volumn 490, Issue 1-2, 2011, Pages 32-36

  Plummer, Prue N ^a   Colson, Natalie J ^a   Lewohl, Joanne M ^a   MacKay, Rachel K ^a   Fernandez, Francesca ^a   Haupt, Larisa M ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Cortical hyperexcitability; Gamma aminobutyric acid (GABA); Genetic susceptibility; Migraine; Multi factorial disorder

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR Q; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR 2; 4 AMINOBUTYRIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MIGRAINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, GABA-B;

EID: 80055050712     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.08.031     Document Type: Article

References (41)

1. Akinci M.K., Schofield P.C. Widespread expression of GABA(A) receptor subunits in peripheral tissues. Neurosci. Res. 1999, 35:145-153.
2. Applied Biosystems User Bulletin No. 2 ABI Prism 7700 Sequence Detection System. Applied Biosystems Available from, Accessed 30 Sept 2009. http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_040980.pdf.
3. Applied Biosystems Primer Express®Applications-Based Primer Design Software. Applied Biosystems Available from, Accessed 30 Sept 2009. http://www3.appliedbiosystems.com/cms/groups/mcb_marketing/documents/generaldocuments/cms_040956.pdf.
4. Belelli D., Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 2005, 6:565-575.
5. Bell M.V., Patterson M.N., Dorkins H.R., Davies K.E. Physical mapping of Dxs134 Close to the Dxs52 Locus. Hum. Genet. 1989, 82:27-30.
6. Bettler B., Kaupmann K., Mosbacher J., Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol. Rev. 2004, 84:835-867.
7. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 2003, 8:721-737.
8. Colson N.J., Fernandez F., Lea R.A., Griffiths L.R. The search for migraine genes: an overview of current knowledge. Cell. Mol. Life Sci. 2007, 64:331-344.
9. Cutrer F.M., Limmroth V., Moskowitz M.A. Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia 1997, 17:93-100.
10. Deprez L., et al. Familial occipitotemporal lobe epilepsy and migraine with visual aura - linkage to chromosome 9q. Neurology 2007, 68:1995-2002.
11. Fierro B., et al. 1 Hz rTMS enhances extrastriate cortex activity in migraine - evidence of a reduced inhibition?. Neurology 2003, 61:1446-1448.
12. Gardiner I.M., Ahmed F., Steiner T.J., McBain A., Kennard C., de Belleroche J. A study of adaptive responses in cell signaling in migraine and cluster headache: correlations between headache type and changes in gene expression. Cephalalgia 1998, 18:192-196.
13. Glatt K., Sinnett D., Lalande M. The human gamma-aminobutyric-acid receptor subunit beta-3 and alpha-5 gene-cluster in chromosome 15q11-Q13 is rich in highly polymorphic (Ca)(N) repeats. Genomics 1994, 19:157-160.
14. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine - studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 1993, 33:48-56.
15. Headache classification committee of the international headache society The International Classification of Headache Disorders, 2nd Edn. Cephalalgia 2004, 24:1-160.
16. Hering-Hanit R. Baclofen for prevention of migraine. Cephalalgia 1999, 19:589-591.
17. Hershey A.D., et al. Genomic abnormalities in patients with migraine and chronic migraine: preliminary blood gene expression suggests platelet abnormalities. Headache 2004, 44:994-1004.
18. Kowa H., Shimomura T., Takahashi K. Platelet gamma-aminobutyric-acid levels in migraine and tension-type headache. Headache 1992, 32:229-232.
19. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657.
20. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma-protein occurs from blood-vessels in dura-mater but not brain. J. Neurosci. 1987, 7:4129-4136.
21. Marukawa H., Shimomura T., Takahashi K. Salivary substance P, 5-hydroxytryptamine, and gamma-aminobutyric acid levels in migraine and tensiontype headache. Headache 1996, 36:100-104.
22. Mathew N.T., et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119-128.
23. Mueller S. Optimizing real-time quantitative PCR experiments with Agilent 2100 bioanalyzer. Agilent Technologies, Inc Available from, Accessed 30 Sept 2009. http://www.chem.agilent.com/enUS/Search/Library/_layouts/Agilent/PublicationSummary.aspx?whid=54545&liid=1805.
24. Mulleners W.M., Chronicle E.P., Palmer J.E., Koehler P.J., Vredeveld J.W. Suppression of perception in migraine - evidence for reduced inhibition in the visual cortex. Neurology 2001, 56:178-183.
25. National Centre for Biotechnology Information Accessed 30 Sept. http://www.ncbi.nlm.nih.gov/.
26. Ng G.Y.K., et al. Identification of a GABA(B) receptor subunit, gb2, required for functional GABA(B) receptor activity. J. Biol. Chem. 1999, 274:7607-7610.
27. Nyholt D.R., Curtain R.P., Griffiths L.R. Familial typical migraine: significant linkage and localization of a gene to Xq24-28. Hum. Genet. 2000, 107:18-23.
28. Palmer J.E., Chronicle E.P., Rolan P., Mulleners W.M. Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. Cephalalgia 2000, 525-532.
29. Pfaffl M.W., Tichopad A., Prgomet C., Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - excel-based tool using pair-wise correlations. Biotechnol. Lett. 2004, 26:509-515.
30. Russell M.B., Iselius L., Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 1996, 16:305-309.
31. Russo L., et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am. J. Hum. Genet. 2005, 76:327-333.
32. Sarchielli P., et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessedictally. Headache 2006, 46:200-207.
33. Schiene K., et al. Neuronal hyperexcitability and reduction of GABA(A)-receptor expression in the surround of cerebral photothrombosis. J. Cereb. Blood Flow Metab. 1996, 16:906-914.
34. Spandidos A., Wang X.W., Wang H.J., Dragnev S., Thurber T., Seed B. A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics 2008, 9:633.
35. Stewart W.F., Staffa J., Lipton R.B., Ottman R. Familial risk of migraine: a population-based study. Ann. Neurol. 1997, 41:166-172.
36. Storer R.J., Akerman S., Goadsby P.J. GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex. Br. J. Pharmacol. 2001, 134:896-904.
37. Storer R.J., Akerman S., Shields K.G., Goadsby P.J. GABA(A) receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res. 2004, 1013:188-193.
38. Vandesompele J., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:1-11.
39. Vieira D.S.S., et al. Cerebrospinal fluid GABA levels in chronic migraine with and without depression. Brain Res. 2006, 1090:197-201.
40. Wallace R.H., et al. Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 2001, 28:49-52.
41. Wilke K., Gaul R., Klauck S.M., Poustka A. A gene in human chromosome band Xq28 (GABRE) defines a putative new subunit class of the GABAA neurotransmitter. Genomics 1997, 45:1-10.